Publicaciones en colaboración con investigadores/as de Boston Children's Hospital (27)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma

    Nature Cancer

2023

  1. Antibodies against endogenous retroviruses promote lung cancer immunotherapy

    Nature, Vol. 616, Núm. 7957, pp. 563-573

  2. Body composition and lung cancer-associated cachexia in TRACERx

    Nature Medicine, Vol. 29, Núm. 4, pp. 846-858

  3. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  4. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

    Nature Medicine

  5. Genomic–transcriptomic evolution in lung cancer and metastasis

    Nature, Vol. 616, Núm. 7957, pp. 543-552

  6. Lung adenocarcinoma promotion by air pollutants

    Nature, Vol. 616, Núm. 7955, pp. 159-167

  7. The Cell Tracking Challenge: 10 years of objective benchmarking

    Nature Methods, Vol. 20, Núm. 7, pp. 1010-1020

  8. The Effects of COVID-19 Lockdown on the Sleep Quality of Children

    CHILDREN-BASEL, Vol. 10, Núm. 6

  9. The evolution of lung cancer and impact of subclonal selection in TRACERx

    Nature, Vol. 616, Núm. 7957, pp. 525-533

  10. The evolution of non-small cell lung cancer metastases in TRACERx

    Nature, Vol. 616, Núm. 7957, pp. 534-542

  11. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

    Nature, Vol. 616, Núm. 7957, pp. 553-562

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma

    Immunity, Vol. 54, Núm. 3, pp. 571-585.e6

2019

  1. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade

    Nature, Vol. 565, Núm. 7737, pp. 43-48

2017

  1. GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma

    Cell Reports, Vol. 21, Núm. 8, pp. 2183-2197

2016

  1. Adherence to the Mediterranean dietary pattern and BMI change among US adolescents

    International Journal of Obesity, Vol. 40, Núm. 7, pp. 1103-1108

2012

  1. Germline deletion of Igh 3′ regulatory region elements hs 5, 6, 7 (hs5-7) affects B cell-specific regulation, rearrangement, and insulation of the Igh locus

    Journal of Immunology, Vol. 188, Núm. 6, pp. 2556-2566

  2. MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo

    Cancer Cell, Vol. 22, Núm. 6, pp. 812-824